Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2014 Oct 24;14(1):246–258. doi: 10.1158/1535-7163.MCT-14-0447

Table 1. Antiproliferative effect of LIMKi on PC cell lines.

All cell lines were treated with half-log serial dilutions of LIMKi for 72 hours. EC50 values were measured from dose-response curves from three independent experiments performed in triplicates.

Cell line LIMKi EC50, μM p value, F test (compared to LNCaP)
LNCaP 1.33 -
CWR22 6.97 <0.0001
LNCaP-AI 11.11 <0.0001
DU145 11.46 <0.0001
PC3 12.68 <0.0001